WO2016061320A3 - Timber therapy for post-traumatic stress disorder - Google Patents

Timber therapy for post-traumatic stress disorder Download PDF

Info

Publication number
WO2016061320A3
WO2016061320A3 PCT/US2015/055687 US2015055687W WO2016061320A3 WO 2016061320 A3 WO2016061320 A3 WO 2016061320A3 US 2015055687 W US2015055687 W US 2015055687W WO 2016061320 A3 WO2016061320 A3 WO 2016061320A3
Authority
WO
WIPO (PCT)
Prior art keywords
timber
therapy
post
stress disorder
traumatic stress
Prior art date
Application number
PCT/US2015/055687
Other languages
French (fr)
Other versions
WO2016061320A2 (en
Inventor
Basant K. PRADHAN
Original Assignee
Rowan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowan University filed Critical Rowan University
Publication of WO2016061320A2 publication Critical patent/WO2016061320A2/en
Publication of WO2016061320A3 publication Critical patent/WO2016061320A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/163—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state by tracking eye movement, gaze, or pupil change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/486—Bio-feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Educational Technology (AREA)
  • Social Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Disabilities (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The disclosure relates to a therapeutic method based on TIMBER (Trauma Interventions using Mindfulness Based Extinction and/or Reconsolidation). TIMBER is a psychotherapy protocol that consists of 2 parts: a brief version (mini-TIMBER) and an elaborate version (full-TIMBER).
PCT/US2015/055687 2014-10-15 2015-10-15 Timber therapy for post-traumatic stress disorder WO2016061320A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462064000P 2014-10-15 2014-10-15
US62/064,000 2014-10-15

Publications (2)

Publication Number Publication Date
WO2016061320A2 WO2016061320A2 (en) 2016-04-21
WO2016061320A3 true WO2016061320A3 (en) 2016-09-29

Family

ID=55747550

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/055687 WO2016061320A2 (en) 2014-10-15 2015-10-15 Timber therapy for post-traumatic stress disorder

Country Status (1)

Country Link
WO (1) WO2016061320A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102608479B1 (en) * 2017-05-25 2023-12-01 글리테크 엘엘씨. Combination therapy for NMDAR antagonist-responsive neuropsychiatric disorders
WO2020163645A1 (en) * 2019-02-06 2020-08-13 Daniel Glasner Biomarker identification
IL296693A (en) * 2020-03-23 2022-11-01 Rustick Joseph Method for treatment of neurological disorders using synaptic pathway training
US20210401774A1 (en) * 2020-06-27 2021-12-30 Robert Brent Turnipseed Ketamine protocols and data evaluation for treatment-resistant depression and trauma

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039468A2 (en) * 2001-11-06 2003-05-15 Haracz John L Antimnemonic therapy for hypermemory syndromes
US20090319347A1 (en) * 2006-07-12 2009-12-24 Henry Albrecht Systems and methods for a holistic well-being assessment
US20110282404A1 (en) * 2008-07-02 2011-11-17 The Board Of Regents, The University Of Texas System Methods for Enhancing Exposure Therapy Using Vagus Nerve Stimulation
US20120295852A1 (en) * 2009-10-05 2012-11-22 Joseph Moskal Methods of treating depression and other related diseases
US20130281798A1 (en) * 2012-04-23 2013-10-24 Sackett Solutions & Innovations, LLC Cognitive biometric systems to monitor emotions and stress

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039468A2 (en) * 2001-11-06 2003-05-15 Haracz John L Antimnemonic therapy for hypermemory syndromes
US20090319347A1 (en) * 2006-07-12 2009-12-24 Henry Albrecht Systems and methods for a holistic well-being assessment
US20110282404A1 (en) * 2008-07-02 2011-11-17 The Board Of Regents, The University Of Texas System Methods for Enhancing Exposure Therapy Using Vagus Nerve Stimulation
US20120295852A1 (en) * 2009-10-05 2012-11-22 Joseph Moskal Methods of treating depression and other related diseases
US20130281798A1 (en) * 2012-04-23 2013-10-24 Sackett Solutions & Innovations, LLC Cognitive biometric systems to monitor emotions and stress

Also Published As

Publication number Publication date
WO2016061320A2 (en) 2016-04-21

Similar Documents

Publication Publication Date Title
EP4331669A3 (en) Selective p2x3 antagonists for use in treating chronic cough without loss of taste response
EP3630975A4 (en) Altered guide rnas for modulating cas9 activity and methods of use
EP3749255A4 (en) Methods, apparatus and devices to treat heart valves
EP3496666A4 (en) Devices and methods for the treatment of heart valve insufficiencies
EP3638235A4 (en) Compounds for modulating s1p1 activity and methods of using the same
EP3523294A4 (en) Calpain modulators and therapeutic uses thereof
EP3463133A4 (en) Therapeutic tissue modulation devices and methods
AU2017261336A1 (en) Modulators of the integrated stress pathway
AU2017260367A1 (en) Modulators of the integrated stress pathway
EP3271011A4 (en) Method, system and apparatus for non-invasive neurostimulation therapy of the brain
AU2017260374A1 (en) Modulators of the integrated stress pathway
EP3270994A4 (en) Methods and apparatus for ventilatory treatment of respiratory disorders
EP3681479A4 (en) Method of administration and treatment
EP3316890A4 (en) Novel breathing control modulating compounds, and methods of making and using same
EP3596111A4 (en) Methods of treating lysosomal disorders
EP3893883A4 (en) Methods for the treatment of depression
WO2016061320A3 (en) Timber therapy for post-traumatic stress disorder
EP3357424A4 (en) Viewer emotion determination apparatus that eliminates influence of brightness, breathing, and pulse, viewer emotion determination system, and program
EP3228085A4 (en) Display apparatus, and method of operating the display apparatus
EP3755312A4 (en) Dosage forms and methods for enantiomerically enriched or pure bupropion
EP3284073A4 (en) Devices and methods for dynamic extracorporeal membrane oxygenation simulation
TW201613639A (en) Methods for treating cardiovascular diseases
EP3331518A4 (en) Combination therapy using acamprosate and d-cycloserine
EP3615502A4 (en) Therapeutic compounds and methods
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15850510

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15850510

Country of ref document: EP

Kind code of ref document: A2